Johnson Fistel, PLLP is investigating whether Select Medical Holdings' board breached fiduciary duties in the proposed $16.50 per share sale to a consortium led by company insiders and Welsh, Carson, Anderson & Stowe. The deal, expected to close mid-2026, would take Select Medical private and delist its shares from the NYSE. The investigation questions if the board maximized shareholder value and if minority shareholders are fairly compensated. Shareholders dissatisfied with the offer are encouraged to join the probe.
Select Medical's board and senior management are under investigation by Bleichmar Fonti & Auld LLP for possible breaches of fiduciary duties related to the company's pending sale at $16.50 per share. The deal, announced in March 2026, involves a cons...
Kaskela Law is investigating the proposed $16.50 per share buyout of Select Medical Holdings Corp. announced in March 2026. The firm questions whether this price fairly compensates shareholders, noting at least one analyst had a $19 price target at t...
Bleichmar Fonti & Auld LLP is investigating Select Medical Holdings Corporation's board and senior management for possible breaches of fiduciary duty related to the company's pending sale at $16.50 per share. The acquisition involves insiders allowed...
